companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

SCHIZOPHRENIA SOCIETYONTARIO

KINGSTON-Canada

Company Name:
Corporate Name:
SCHIZOPHRENIA SOCIETYONTARIO
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 275 Bagot St #301,KINGSTON,ON,Canada 
ZIP Code:
Postal Code:
K7L3G4 
Telephone Number: 6135492485 
Fax Number: 6135498290 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
806301 
USA SIC Description:
Mental Health Services 
Number of Employees:
1 to 4 
Sales Amount:
Less than $500,000 
Credit History:
Credit Report:
Very Good 
Contact Person:
Rebecca Ward 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
SIMONYIELMER, SYLVIA
SEVENTHDAY ADVENTIST CHURCH
SCIENCE 44 COOP
Next company profile:
SCHAAFLEIBL, E DDS
SANGSTERGIBSON, S MD
SALVATION ARMYCORRECTIONAL SV










Company News:
  • News - Schizophrenia. com
    Please post and discuss news, and videos, etc on the latest developments in schizophrenia research, treatments, and related issues
  • Findings From First Cohort of SPG302 in Phase 2 Alzheimer Disease Trial . . .
    The results for SPG302 in a Phase 2a Study for Alzheimer were published a couple days ago at the 2025 Alzheimer’s Association International Conference It’s pretty encouraging ! It’s the same molecule that is been trialed for ALS and Schizophrenia It regenerates glutamatergic synapses For the Schizophrenia phase 2 trial, the studies are now completed in the Australian locations The
  • Schizophrenia. com - Schizophrenia Discussion Community for People Diagnosed
    Schizophrenia Discussion Community for People Diagnosed, or who think they may have Psychosis
  • Work while being diagnosed with schizophrenia - DXd - Other . . .
    Journaling and exercise are a couple of other wellness tools for myself to deal with the stress I found a good occupation that I feel a lot of us diagnosed with schizophrenia should try And that is Peer Support Specialist work We have lived experience or some mental illness and work with others to help them in their recovery process
  • When to Use Cobenfy Over Clozapine - News - Schizophrenia. com
    When to Use Cobenfy Over Clozapine, With Chelsie Monroe, APN At So Cal Psych 2025, Monroe discusses the promise of xanomeline-trospium (Cobenfy) and its novel mechanism
  • New global treatment guidelines for schizophrenia - News . . .
    New global treatment guidelines for schizophrenia - InSight+ The INTEGRATE project offers a concise, algorithmic guideline for schizophrenia pharmacotherapy, co-designed by global experts and those with lived experience Schizophrenia affects almost 1% of Australians It remains one of the most severe and
  • Is all the thoughts in my head my own thoughts? - DXd - Other . . .
    The honest answer is: not always Not all the thoughts in your head are truly your own—especially when you’re dealing with schizophrenia When the illness is active, it can create thoughts, voices, or feelings that seem to come from inside you but actually aren’t from the real you These can be: Intrusive thoughts that are disturbing or violent Voices that speak as if they’re other
  • Cobenfy ARISE Trial Results - News - Schizophrenia. com
    Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia Cobenfy as an adjunctive treatment to atypical antipsychotics did not reach the threshold for a statistically significant difference compared to placebo with an atypical antipsychotic for




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer